Deficiencies of Magnesium Replacement in the Critically Ill

Affiliations

¹ 1 Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA.
² 2 Department of Pharmacy Practice, University of Arkansas for Medical Sciences Medical Center, Little Rock, AR, USA.

Comment

Drayton A Hammond et al. J Intensive Care Med. 2018 May.

. 2018 May;33(5):327.

doi: 10.1177/0885066617735785.

¹ 1 Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA.
² 2 Department of Pharmacy Practice, University of Arkansas for Medical Sciences Medical Center, Little Rock, AR, USA.

No abstract available

Comment on

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
Woods KL, Fletcher S, Roffe C, Haider Y. Woods KL, et al. Lancet. 1992 Jun 27;339(8809):1553-8. doi: 10.1016/0140-6736(92)91828-v. Lancet. 1992. PMID: 1351547 Clinical Trial.
Intravenous magnesium in acute myocardial infarction.
Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Rasmussen HS, et al. Lancet. 1986 Feb 1;1(8475):234-6. doi: 10.1016/s0140-6736(86)90773-7. Lancet. 1986. PMID: 2868254 Clinical Trial.
Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy.
Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Shechter M, et al. Am J Cardiol. 1995 Feb 15;75(5):321-3. doi: 10.1016/s0002-9149(99)80546-3. Am J Cardiol. 1995. PMID: 7856520 Clinical Trial.
Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.
Raghu C, Peddeswara Rao P, Seshagiri Rao D. Raghu C, et al. Int J Cardiol. 1999 Dec 1;71(3):209-15. doi: 10.1016/s0167-5273(99)00125-4. Int J Cardiol. 1999. PMID: 10636525 Clinical Trial.